Protocols
2 protocol(s) meet the specified criteria
PI: Sanoff, Hanna Kelly
Protocol No.TitleStatus
LCCC1317GENIC, A Genotype-Directed Phase II Study Of Higher Dose Of Irinotecan In First-Line Metastatic Colorectal Cancer Patients Treated With FOLFIRI Plus Bevacizumab.Open
NRG-GI004-CIRBColorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal CancerOpen